tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Monte Rosa Therapeutics: Promising Developments and Financial Stability Support Buy Rating
PremiumRatingsMonte Rosa Therapeutics: Promising Developments and Financial Stability Support Buy Rating
3M ago
Monte Rosa Therapeutics Reports Strong Q1 2025 Results
Premium
Company Announcements
Monte Rosa Therapeutics Reports Strong Q1 2025 Results
3M ago
Monte Rosa Therapeutics reports Q1 revenue $84.929M vs $1.064M last year
Premium
The Fly
Monte Rosa Therapeutics reports Q1 revenue $84.929M vs $1.064M last year
3M ago
Promising Clinical Developments and Strategic Partnerships Drive Buy Rating for Monte Rosa Therapeutics
PremiumRatingsPromising Clinical Developments and Strategic Partnerships Drive Buy Rating for Monte Rosa Therapeutics
4M ago
Monte Rosa Therapeutics price target lowered to $10 from $11 at Wells Fargo
Premium
The Fly
Monte Rosa Therapeutics price target lowered to $10 from $11 at Wells Fargo
4M ago
Monte Rosa Therapeutics Reports Strong Q4 2024 Results
Premium
Company Announcements
Monte Rosa Therapeutics Reports Strong Q4 2024 Results
4M ago
Monte Rosa Therapeutics reports Q4 revenue $60.6M, consensus $51.9M
PremiumThe FlyMonte Rosa Therapeutics reports Q4 revenue $60.6M, consensus $51.9M
4M ago
Monte Rosa Therapeutics announces results from MRT-6160, MRT-2359 programs
Premium
The Fly
Monte Rosa Therapeutics announces results from MRT-6160, MRT-2359 programs
4M ago
Monte Rosa Therapeutics, Inc. (GLUE) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Monte Rosa Therapeutics, Inc. (GLUE) Q4 Earnings Cheat Sheet
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100